CIK 0001512762
- Accelerated filer
- Smaller reporting company
Coherus Oncology, Inc.
Sign in to watch- Ticker
- CHRS
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 273615821
- Phone
- +1 650-649-3530
- Business address
- C/O DENNIS M. LANFEAR, 333 TWIN DOLPHIN DR, SUITE 600, REDWOOD CITY, CA, 94065
- Former names
- Coherus BioSciences, Inc., BioGenerics, Inc.
- 4 Derivatives Options or other derivatives
- 4 Grant or award Chief Operating Officer acquired 20,000 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 20,000 shares (grant or award)
- 4 Grant or award Chief Scientific Officer acquired 20,000 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale Chief Scientific Officer sold 114,240 shares at $16.25 ($1,856,263)
- 4 Open-market sale Chief Operating Officer sold 26,649 shares at an average $15.46 ($412,065)
- 4 Open-market sale Chief Operating Officer sold 2,488 shares at $17.45 ($43,418)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Chief Financial Officer sold 7,402 shares at $21.55 ($159,513)
- 4 Open-market sale Chief Financial Officer sold 46,144 shares at an average $19.95 ($920,736)
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Chief Operating Officer sold 2,500 shares at $17.94 ($44,852)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 7 of 20 · 399 filings